EFFICACY AND SAFETY OF PEGINTERFERON ALFA-2A 360 μG/WEEK IN COMBINATION WITH RIBAVIRIN IN HEPATITIS C GENOTYPE I PATIENTS WITH CIRRHOSIS: ANALYSIS FROM THE CHARIOT STUDY

被引：1

作者：

Cheng, W. S. C. ^{[1
]}

Roberts, S. ^{[2
]}

Weltman, M. ^{[3
]}

Crawford, D. H. G. ^{[4
]}

Sievert, W. ^{[5
]}

McCaughan, G. ^{[6
]}

Rawlinson, W. ^{[7
]}

Desmond, P. ^{[8
]}

Yoshihara, M. ^{[9
]}

Rizkalla, B. ^{[9
]}

DePamphilis, J. ^{[11
]}

Marks, P. ^{[10
]}

Dore, G. J. ^{[10
]}

机构：

[1] Royal Perth Hosp, Perth, WA, Australia

[2] Alfred Hosp, Melbourne, Vic, Australia

[3] Nepean Hosp, Sydney, NSW, Australia

[4] Greenslopes Hosp, Brisbane, Qld, Australia

[5] Monash Med Ctr, Melbourne, Vic, Australia

[6] Royal Prince Alfred Hosp, Sydney, NSW, Australia

[7] Prince Wales Hosp, SEALS, Sydney, NSW, Australia

[8] St Vincents Hosp, Melbourne, Vic, Australia

[9] Roche Prod Ltd, Sydney, NSW, Australia

[10] Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW, Australia

[11] Roche, Nutley, NJ USA

来源：

关键词：

D O I：

10.1016/S0168-8278(09)60603-6

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

100201 [内科学];

摘要：

601

引用

页码：S221 / S221

页数：1